LOGAN, Utah, Oct. 15 /PRNewswire/ -- Facet Solutions, Inc. announced today that it has completed one year follow-up on the first cohort of patients to receive its Anatomic Facet Replacement System (AFRS(TM)). The clinical outcomes for these patients at one year include a significant decline in leg and back pain; improved motion and function; and no post-operative complications. Additionally, the first patient in the AFRS(TM) study has completed the two year follow up evaluation with similarly positive results.
The AFRS(TM) has been developed by Facet Solutions, Inc. to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The AFRS(TM) procedure includes replacing the diseased facet joint with an anatomic implant that restores the natural motion, stability, and balance to the lumbar spine.
An international team of Orthopedic surgeons began the initial AFRS(TM) study at the Hospital Servidor Publico Estadol in Sao Paulo in late September 2005. The team included Dr. Allen Carl of Albany Medical Center in Albany, New York and Dr. Carlos Oliveira of Sao Paulo, Brazil.
"I believe that the early clinical results for the AFRS(TM) clearly demonstrate that this new treatment option is improving the quality of life for my patients who would otherwise lose significant motion using current fusion or dynamic stabilization devices," Dr. Oliviera stated. "In fact, many of my patients were having fusions and would come back four and five years later needing a subsequent fusion at adjacent levels as a result of the reduction in motion at the original fused level of the spine. I anticipate that this technology will ultimately become the surgical standard of care for spinal stenosis patients in the future."
"Facet Solutions is very pleased with the early clinical experience," added Eric Bannon, VP of Clinical Affairs. "The company looks forward to expanding this clinical outcome data with results from an ongoing FDA approved IDE Study which was recently expanded to eight sites within the United States."
The summary findings from this evaluation will be presented a the Science of Facet Joint Repair and Total Posterior Arthroplasty Symposium which will be held in Austin, Texas at the Omni Hotel on Monday, October 22, 2007 at 6:30 PM.
* Note: AFRS(TM) is an investigational device in the United States. It is
limited by United States (U.S.) Federal Law for investigational use
About Facet Solutions
Facet Solutions, Inc. is a privately held, venture backed company that is focused on developing and commercializing surgical devices for the treatment of facet related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.
|SOURCE Facet Solutions, Inc.|
Copyright©2007 PR Newswire.
All rights reserved